BamSEC and AlphaSense Join Forces
Learn More

Entero Therapeutics Inc.

NASDAQ: ENTO    
Share price (1/8/25): $0.62    
Market cap (1/8/25): $2.947 million

Material Contracts Filter

EX-10.1
from 8-K 8 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 12 pages Armistice Capital Master Fund Ltd. C/O Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, Ny 10022 Re: Reprice and Reload Offer of Common Stock Purchase Warrants to Whom It May Concern
12/34/56
EX-10.2
from 8-K 28 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages Placement Agency Agreement
12/34/56
EX-10.53
from 10-K 28 pages Securities Purchase Agreement
12/34/56
EX-10.7
from 8-K 1 page A Semi-Monthly Rate of $14,583.34 Which Annualizes to $350,000.00. This Position Is Considered Exempt Under the Federal and State Wage and Hour Laws, Which Means You Are Not Eligible for Overtime Pay Beyond Your Salary. · an Incentive Bonus of Up to 40% of Your Annual Salary Which Is Dependent on Meeting Pre-Determined Objectives at the Sole Discretion of the Company. · You Will Be Eligible to Participate in Company Benefits on Your First Day of Employment Including Medical, Dental, Vision, Disability, Life Insurance and 401k Plan. Benefit Costs Will Be Covered at 100% by the Company for You and Your Eligible Dependents for the Following: Medical, Dental, Vision. · You Will Receive (3) Three Weeks of Paid Vacation Per Annum, Which Shall Accrue and Will Otherwise Be Subject to the Company's Established Policies. Sick Leave and Holidays Will Also Be Provided in Accordance With the Company's Established Policies. /S/ James Sapirstein James Sapirstein Chairman, President and CEO I Accept the Offer of Employment Set Forth Above. Signature: /S/ Jack Syage Date: March 13, 2024
12/34/56
EX-10.7
from DEFA14A 1 page A Semi-Monthly Rate of $14,583.34 Which Annualizes to $350,000.00. This Position Is Considered Exempt Under the Federal and State Wage and Hour Laws, Which Means You Are Not Eligible for Overtime Pay Beyond Your Salary. · an Incentive Bonus of Up to 40% of Your Annual Salary Which Is Dependent on Meeting Pre-Determined Objectives at the Sole Discretion of the Company. · You Will Be Eligible to Participate in Company Benefits on Your First Day of Employment Including Medical, Dental, Vision, Disability, Life Insurance and 401k Plan. Benefit Costs Will Be Covered at 100% by the Company for You and Your Eligible Dependents for the Following: Medical, Dental, Vision. · You Will Receive (3) Three Weeks of Paid Vacation Per Annum, Which Shall Accrue and Will Otherwise Be Subject to the Company's Established Policies. Sick Leave and Holidays Will Also Be Provided in Accordance With the Company's Established Policies. /S/ James Sapirstein James Sapirstein Chairman, President and CEO I Accept the Offer of Employment Set Forth Above. Signature: /S/ Jack Syage Date: March 13, 2024
12/34/56
EX-10.6
from DEFA14A 7 pages Form of Patent and Trademark Security Agreement
12/34/56
EX-10.6
from 8-K 7 pages Form of Patent and Trademark Security Agreement
12/34/56
EX-10.5
from DEFA14A 3 pages Form of Secured Promissory Note , 2024 $
12/34/56
EX-10.5
from 8-K 3 pages Form of Secured Promissory Note , 2024 $
12/34/56
EX-10.4
from 8-K 2 pages Lender Support Letter
12/34/56
EX-10.4
from DEFA14A 2 pages Lender Support Letter
12/34/56
EX-10.3
from 8-K 16 pages Security Agreement
12/34/56
EX-10.3
from DEFA14A 16 pages Security Agreement
12/34/56
EX-10.2
from 8-K 28 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 15 pages Placement Agency Agreement
12/34/56
EX-10.1
from 8-K 12 pages Armistice Capital Master Fund Ltd. C/O Armistice Capital, LLC 510 Madison Avenue, 7th Floor New York, Ny 10022 Re: Reprice and Reload Offer of Common Stock Purchase Warrants to Whom It May Concern
12/34/56
EX-10.50
from S-1/A 27 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K/A 54 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type That the Company Treats as Private or Confidential. the Redacted Terms Have Been Marked With Three Asterisks [***] License Agreement Between Sanofi and First Wave Biopharma, Inc. Dated as of September 13, 2023
12/34/56